#CRISPR

Scientists have discovered a swifter and more precise way to edit the genome of immune cells, opening doors for cancer and HIV therapies.

Scientists have discovered a swifter and more precise way to edit the genome of immune cells, opening doors for cancer and HIV therapies.

Gilead Sciences’ second round of cure grants supports these five research projects.

This Ohio researcher will be using CRISPR gene editing to target HIV, thanks to funding from The Campbell Foundation.

For the first time, scientists have used the powerful, cutting-edge CRISPR/Cas9 gene-editing method to snip HIV out of infected mice.

The feat marks an important milestone in the mammoth effort to find a cure for HIV.

An amfAR grant goes to two University of Massachusetts scientists exploring a novel technique.

Researchers have used the cutting-edge CRISPR/Cas9 gene-editing technology to identify five potential targets for HIV treatments.

Because these targets are human genes, therapies that go after them would be less susceptible to drug resistance.

Scientists have used the CRISPR/Cas9 gene-editing method to snip out a key fragment of HIV’s genetic code from the cells of live rodents.

A slew of media outlets erroneously reported that scientists might be just three years away from developing a cure for HIV.

Scientists have used the cutting-edge CRISPR/Cas9 gene-editing method to excise a key fragment of HIV’s genetic code from live rodents.

HIV can become resistant to CRISPR/Cas9 gene editing just as with antiretroviral (ARV) treatment.

Scientists have succeeded in editing HIV out of infected cells without apparently harming their ability to function.